Can Erythrocyte Sedimentation Rate (ESR) and C-Reactive Protein (CRP) differentiate between cellulitis and acute hematogenous osteomyelitis in diabetic patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

ESR and CRP cannot reliably differentiate between cellulitis and acute hematogenous osteomyelitis in diabetic patients. Both inflammatory markers are typically elevated in both conditions, making them useful for detecting inflammation but not for distinguishing between these specific infections. While higher values may suggest osteomyelitis, there is significant overlap in the ranges seen in both conditions. Diabetic patients often have baseline elevations in these markers, further complicating interpretation.

Key Points to Consider

  • The diagnosis of osteomyelitis in diabetic patients is challenging and requires a comprehensive approach, including physical examination, imaging studies, and laboratory tests 1.
  • The probe-to-bone test, plain X-rays, and ESR or CRP can be used as initial studies to diagnose osteomyelitis, but MRI is the most sensitive imaging method for diagnosing osteomyelitis 1.
  • Blood cultures should be obtained before starting antibiotics to identify the causative organism in hematogenous osteomyelitis.
  • A definitive diagnosis of osteomyelitis usually requires positive results on both histological and microbiological examinations of an aseptically obtained bone sample 1.
  • The IWGDF/IDSA guidelines recommend using a combination of diagnostic tests, including probe-to-bone, serum inflammatory markers, plain X-ray, and MRI or radionuclide scanning, to diagnose osteomyelitis 1.

Diagnostic Approach

For accurate diagnosis, clinicians should combine ESR and CRP tests with other diagnostic modalities, such as MRI, bone scans, or bone biopsy. Physical examination findings like bone tenderness, depth of infection, and presence of ulcers provide important clinical context. The diagnostic approach should be comprehensive rather than relying solely on inflammatory markers, especially in diabetic patients where the stakes of missed bone infection are high 1.

From the Research

Differentiation between Cellulitis and Acute Hematogenous Osteomyelitis

  • Erythrocyte Sedimentation Rate (ESR) and C-Reactive Protein (CRP) are commonly used inflammatory biomarkers to evaluate foot infections in diabetic patients.
  • A study published in 2019 2 determined the optimal cutoff values for ESR and CRP to diagnose osteomyelitis in patients with diabetes-related foot infections.
  • The optimal cutoff values were found to be an ESR of 60 mm/h and a CRP level of 7.9 mg/dL, with sensitivity and specificity of 74% and 56% for ESR, and 49% and 80% for CRP, respectively.

Diagnostic Algorithm

  • The study 2 suggested a diagnostic algorithm using ESR and CRP to improve recognition of osteomyelitis in diabetic foot infections.
  • If the ESR is < 30 mm/h, the likelihood of osteomyelitis is low.
  • If ESR is > 60 mm/h and CRP level is > 7.9 mg/dL, the likelihood of osteomyelitis is high, and treatment of suspected osteomyelitis should be strongly considered.
  • While ESR is better for ruling out osteomyelitis initially, CRP helps distinguish osteomyelitis from soft-tissue infection in patients with high ESR values.

Limitations and Challenges

  • Diagnosing infection in the diabetic foot can be challenging, and determining whether infection is present in bone can be especially difficult 3.
  • Soft-tissue cultures may not predict bone cultures with sufficient reliability, and bone and deep soft tissue specimens should be obtained from patients with suspected osteomyelitis 4.
  • Imaging tests, such as magnetic resonance imaging, and newer molecular microbial techniques may be helpful in diagnosing diabetic foot infections 3, 5, 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Challenges in diagnosing infection in the diabetic foot.

Diabetic medicine : a journal of the British Diabetic Association, 2015

Research

Pathogens isolated from deep soft tissue and bone in patients with diabetic foot infections.

Journal of the American Podiatric Medical Association, 2008

Research

Osteomyelitis of the foot in diabetic patients.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1997

Research

Effect of soft-tissue pathology on detection of pedal osteomyelitis in diabetics.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1985

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.